Contractor intelligence · computed from public award records
ZETA PHARMA
- Awards won
- 22
- Known value
- USD 2.2M
- First award
- 11 Nov 2018
- Most recent
- 18 Aug 2019
Wins by funder
| Funder | Awards | Known value | Most recent |
|---|---|---|---|
| World Bank | 22 | USD 2.2M | 18 Aug 2019 |
Where the work is
EG · 22
Sources
The most recent award records behind the figures above. Every number on this page is computed from records like these — nothing is estimated or editorial.
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 18 Aug 2019 · USD 102K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 18 Aug 2019 · USD 16K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 01 Aug 2019 · USD 102K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 13 Jun 2019 · USD 109K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 13 Jun 2019 · USD 105K · World Bank
- Procurement of virus c drugs ( Sofosbuvir 400mg ,Daclatasvir 60 mg ) · 13 Jun 2019 · USD 106K · World Bank
- Purchasing of Hep-C medications · 13 Jun 2019 · USD 105K · World Bank
- Purchasing of Hep-C medications · 13 Jun 2019 · USD 105K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 13 Jun 2019 · USD 105K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 13 Jun 2019 · USD 110K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 13 Jun 2019 · USD 109K · World Bank
- Purchase of hepatitis C drugs (Sofosbuvir400mg ,Daclatasvir 60 mg drugs ) · 13 Jun 2019 · USD 110K · World Bank
- Hepatitis c drugs · 13 Jun 2019 · USD 110K · World Bank
- alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs · 13 May 2019 · USD 111K · World Bank
- Procurement of virus c medications (the sofosbuvir 400mg, Daclatasvir 60 mg drugs) · 24 Mar 2019 · USD 106K · World Bank
- all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 12 Nov 2018 · USD 95K · World Bank
- all technical offers are accepted for The Sofosbuvir 400mg , Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 96K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 96K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 95K · World Bank
- all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs · 11 Nov 2018 · USD 95K · World Bank
Method
Computed from 22 award records ingested from official disclosure sources (World Bank, Inter-American Development Bank, and published contract-award notices). Values are shown in USD where the source published one; entity identity is resolved conservatively and reviewed. GLODA is not affiliated with any funder or contractor shown. Last computed 15 Sept 2026.